Deciphering cancer. Advancing patient care. Deciphering cancer. Advancing patient care. Deciphering cancer. Advancing patient care.
 

Deciphering cancer.
Advancing patient care.
Learn More

 
PRODUCT DEVELOPMENT PIPELINE

Deciphera’s proprietary switch control platform has generated a broad clinical pipeline of kinase inhibitors including tumor-targeted therapies and immuno-targeted therapies.

KINASE SWITCH CONTROL INHIBITOR PLATFORM
Deciphera's switch control inhibitors are designed to address key limitations of current cancer therapies by selectively blocking kinase activation.
Back to Top